Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN   ACTAVIS
EQUITY SHARE DATA
    LUPIN
Mar-23
ACTAVIS
Dec-18
LUPIN/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs79916,126-   
Low Rs58310,818-   
Sales per share (Unadj.) Rs365.83,955.8-  
Earnings per share (Unadj.) Rs9.8-1,274.2-  
Cash flow per share (Unadj.) Rs29.2416.9-  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs270.716,315.7-  
Shares outstanding (eoy) m454.98332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.93.4 55.5%   
Avg P/E ratio x70.2-10.6 -664.2%  
P/CF ratio (eoy) x23.732.3 73.2%  
Price / Book Value ratio x2.60.8 309.2%  
Dividend payout %40.70-   
Avg Mkt Cap Rs m314,3814,480,758 7.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m30,8720-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m166,4171,315,689 12.6%  
Other income Rs m1,50925,160 6.0%   
Total revenues Rs m167,9261,340,849 12.5%   
Gross profit Rs m17,20634,478 49.9%  
Depreciation Rs m8,807562,428 1.6%   
Interest Rs m2,74375,923 3.6%   
Profit before tax Rs m7,165-578,713 -1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m2,688-7,334 -36.7%   
Profit after tax Rs m4,477-423,784 -1.1%  
Gross profit margin %10.32.6 394.5%  
Effective tax rate %37.51.3 2,960.4%   
Net profit margin %2.7-32.2 -8.4%  
BALANCE SHEET DATA
Current assets Rs m124,513539,627 23.1%   
Current liabilities Rs m92,654477,372 19.4%   
Net working cap to sales %19.14.7 404.6%  
Current ratio x1.31.1 118.9%  
Inventory Days Days2620 133.9%  
Debtors Days Days9866 148.2%  
Net fixed assets Rs m103,490148,929 69.5%   
Share capital Rs m9100-   
"Free" reserves Rs m122,2460-   
Net worth Rs m123,1565,426,601 2.3%   
Long term debt Rs m2751,910,903 0.0%   
Total assets Rs m228,0038,483,012 2.7%  
Interest coverage x3.6-6.6 -54.5%   
Debt to equity ratio x00.4 0.6%  
Sales to assets ratio x0.70.2 470.6%   
Return on assets %3.2-4.1 -77.2%  
Return on equity %3.6-7.8 -46.5%  
Return on capital %8.0-4.8 -165.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m26,3060-   
CASH FLOW
From Operations Rs m18,972470,046 4.0%  
From Investments Rs m-12,868258,229 -5.0%  
From Financial Activity Rs m-3,373-806,740 0.4%  
Net Cashflow Rs m2,732-78,073 -3.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare LUPIN With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare LUPIN With: ORTIN LABS   JENBURKT PH.  DENIS CHEM LAB  LYKA LABS  SAKAR HEALTHCARE   



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.